2-arachidonoylglycerol might be a novel therapeutic target in the treatment of cardiovascular disease

Recently, we have read with great interest the published paper by Julian et al. [ [1] Jehle J. Eich L. Danisch M. et al. The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair. Int. J. Cardiol. 2021; 323: 243-250 Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar ] and subsequent correspondence by Hou et al. [ [2] Hou L.J. Xie M.Y. Ye W. et al. The endocannabinoid 2-arachidonoylglycerol inhibits...